Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
The latest announcement is out from Pro Medicus Limited ( (AU:PME) ).
Pro Medicus Limited’s U.S. subsidiary, Visage Imaging, has secured a A$53 million, 7-year contract with BayCare, a prominent healthcare system in Florida. This agreement marks a significant expansion into the North American integrated delivery network market, utilizing the company’s cloud-based Visage 7 Enterprise Imaging Platform to enhance diagnostic imaging services across BayCare’s extensive network. This deal underscores Pro Medicus’s strategic focus on cloud-based solutions in the healthcare IT market, reinforcing its position as a leader in medical imaging technology.
More about Pro Medicus Limited
Pro Medicus Limited is a leading healthcare informatics company founded in 1983. It provides a comprehensive range of medical imaging software and services to hospitals, imaging centers, and healthcare groups globally. The acquisition of Visage Imaging in 2009 has positioned Pro Medicus as a global provider of advanced medical imaging solutions.
YTD Price Performance: 6.81%
Average Trading Volume: 351
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $17.8B
See more insights into PME stock on TipRanks’ Stock Analysis page.
